
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (25): 3075-3082.DOI: 10.12114/j.issn.1007-9572.2022.0515
Special Issue: 神经退行性病变最新文章合辑; 述评栏目最新文章合辑
• Editorial • Next Articles
Received:2022-07-14
Revised:2022-07-18
Published:2022-09-05
Online:2022-07-21
Contact:
Wannian LIANG
About author:
通讯作者:
梁万年
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0515
| 行动领域 | 英国 | 英国北爱尔兰地区 | 澳大利亚 | 卢森堡 | 以色列 | 芬兰 | 爱尔兰 | 希腊 | 意大利 | 美国 | 挪威 | 马耳他 | 韩国 | 印度尼西亚 | 古巴 | 奥地利 | 斯洛文尼亚 | 瑞士 | 英国苏格兰地区 | WHO | 加拿大 | 威尔士 | 丹麦 | 卡塔尔 | 捷克 | 荷兰 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 预防 | 失智症友好意识 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | √ | - | √ | √ | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ |
| 减少危险因素,推迟失智症的发生 | - | √ | - | √ | - | - | - | √ | √ | √ | √ | - | √ | √ | - | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| 发布失智症国家(地区)框架和标准策略 | √ | √ | - | - | √ | - | - | - | - | - | - | √ | - | - | - | √ | - | √ | √ | - | - | - | - | √ | √ | √ | |
| 失智症作为公共卫生优先事项 | - | - | - | √ | √ | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | √ | √ | - | - | √ | - | - | |
| 识别和描述早期认知障碍 | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | √ | - | - | - | - | - | - | - | - | - | - | - | |
| 基于社区的预防和管理 | - | - | - | - | - | - | - | - | - | - | √ | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 促进大脑健康 | - | - | - | - | - | √ | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | |
| 干预 | 失智症诊断、治疗、照护及干预 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | - | √ | √ | √ | √ | √ | √ | - | √ | - | - |
| 减少不适当的抗精神病药物处方 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | √ | - | - | - | - | - | - | - | |
| 失智症患者的注册、分类管理 | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 对有失踪风险的患者做出快速响应 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | |
| 研究 | 建设失智症信息系统 | - | - | - | √ | - | - | √ | √ | √ | √ | - | - | - | √ | - | √ | √ | √ | √ | √ | - | - | - | √ | - | √ |
| 失智症研究、教育和创新 | - | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| 患者在社会建筑环境中生活得更好 | √ | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | √ | - | √ | - | - | √ | - | - | √ | - | |
| 开发卫生和社会福利技术 | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 技术的可获得性 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | |
| 支持 | 对失智症照料者的支持 | - | √ | - | √ | √ | √ | √ | √ | √ | √ | - | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| 扩大不同护理服务主体的协调与合作 | - | - | - | - | - | - | - | - | √ | - | √ | - | - | √ | - | √ | - | - | √ | - | - | - | √ | √ | √ | √ | |
| 提高照护人员专业发展 | - | - | - | - | - | - | - | - | √ | - | - | √ | - | √ | √ | - | - | - | - | - | - | - | - | - | - | √ | |
| 确保患者和护理人员的参与性和自主性 | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | √ | - | - | √ | - | - | - | - | - | - | - | |
| 实施 | 建立战略领导管理小组 | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | √ |
| 保障行动计划实施所需资源 | - | √ | - | - | - | - | - | - | - | √ | - | √ | - | √ | - | - | - | - | √ | - | - | √ | √ | √ | |||
| 优化利益相关者的作用 | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | √ | - | - | - | - | - | - | - | |
| 立法 | 护理人员的道德和赋权 | - | - | - | √ | - | - | - | - | √ | - | - | √ | - | - | - | - | √ | - | √ | - | - | - | - | - | - | - |
| 保护失智症患者的权益 | - | √ | - | √ | - | - | - | √ | - | - | - | - | - | √ | √ | - | - | - | √ | - | - | - | - | √ | √ | - | |
| 评估 | 持续护理、临终支持的质量 | - | √ | √ | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | √ | - | √ | √ | √ | √ | - | √ |
| 服务的经济可持续性 | - | - | - | - | - | - | - | - | - | - | √ | - | √ | - | - | - | - | √ | - | - | - | - | √ | - | √ | - | |
| 结果完成情况、时间进度 | - | - | - | - | - | - | - | - | √ | √ | - | - | - | √ | - | - | - | - | - | - | - | - | - | √ | - | √ | |
Table 1 Priorities in the action plans on dementia from the WHO and 25 countries/regions
| 行动领域 | 英国 | 英国北爱尔兰地区 | 澳大利亚 | 卢森堡 | 以色列 | 芬兰 | 爱尔兰 | 希腊 | 意大利 | 美国 | 挪威 | 马耳他 | 韩国 | 印度尼西亚 | 古巴 | 奥地利 | 斯洛文尼亚 | 瑞士 | 英国苏格兰地区 | WHO | 加拿大 | 威尔士 | 丹麦 | 卡塔尔 | 捷克 | 荷兰 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 预防 | 失智症友好意识 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | √ | - | √ | √ | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ |
| 减少危险因素,推迟失智症的发生 | - | √ | - | √ | - | - | - | √ | √ | √ | √ | - | √ | √ | - | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| 发布失智症国家(地区)框架和标准策略 | √ | √ | - | - | √ | - | - | - | - | - | - | √ | - | - | - | √ | - | √ | √ | - | - | - | - | √ | √ | √ | |
| 失智症作为公共卫生优先事项 | - | - | - | √ | √ | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | √ | √ | - | - | √ | - | - | |
| 识别和描述早期认知障碍 | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | √ | - | - | - | - | - | - | - | - | - | - | - | |
| 基于社区的预防和管理 | - | - | - | - | - | - | - | - | - | - | √ | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 促进大脑健康 | - | - | - | - | - | √ | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | |
| 干预 | 失智症诊断、治疗、照护及干预 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | - | √ | √ | √ | √ | √ | √ | - | √ | - | - |
| 减少不适当的抗精神病药物处方 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | √ | - | - | - | - | - | - | - | |
| 失智症患者的注册、分类管理 | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 对有失踪风险的患者做出快速响应 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | |
| 研究 | 建设失智症信息系统 | - | - | - | √ | - | - | √ | √ | √ | √ | - | - | - | √ | - | √ | √ | √ | √ | √ | - | - | - | √ | - | √ |
| 失智症研究、教育和创新 | - | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| 患者在社会建筑环境中生活得更好 | √ | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | √ | - | √ | - | - | √ | - | - | √ | - | |
| 开发卫生和社会福利技术 | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 技术的可获得性 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | |
| 支持 | 对失智症照料者的支持 | - | √ | - | √ | √ | √ | √ | √ | √ | √ | - | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| 扩大不同护理服务主体的协调与合作 | - | - | - | - | - | - | - | - | √ | - | √ | - | - | √ | - | √ | - | - | √ | - | - | - | √ | √ | √ | √ | |
| 提高照护人员专业发展 | - | - | - | - | - | - | - | - | √ | - | - | √ | - | √ | √ | - | - | - | - | - | - | - | - | - | - | √ | |
| 确保患者和护理人员的参与性和自主性 | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | √ | - | - | √ | - | - | - | - | - | - | - | |
| 实施 | 建立战略领导管理小组 | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | √ |
| 保障行动计划实施所需资源 | - | √ | - | - | - | - | - | - | - | √ | - | √ | - | √ | - | - | - | - | √ | - | - | √ | √ | √ | |||
| 优化利益相关者的作用 | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | √ | - | - | - | - | - | - | - | |
| 立法 | 护理人员的道德和赋权 | - | - | - | √ | - | - | - | - | √ | - | - | √ | - | - | - | - | √ | - | √ | - | - | - | - | - | - | - |
| 保护失智症患者的权益 | - | √ | - | √ | - | - | - | √ | - | - | - | - | - | √ | √ | - | - | - | √ | - | - | - | - | √ | √ | - | |
| 评估 | 持续护理、临终支持的质量 | - | √ | √ | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | √ | - | √ | √ | √ | √ | - | √ |
| 服务的经济可持续性 | - | - | - | - | - | - | - | - | - | - | √ | - | √ | - | - | - | - | √ | - | - | - | - | √ | - | √ | - | |
| 结果完成情况、时间进度 | - | - | - | - | - | - | - | - | √ | √ | - | - | - | √ | - | - | - | - | - | - | - | - | - | √ | - | √ | |
| [1] |
中国痴呆与认知障碍诊治指南写作组,中国医师协会神经内科医师分会认知障碍疾病专业委员会.中国阿尔茨海默病一级预防指南[J].中华医学杂志,2020,100(35):2721-2735. DOI:10.3760/cma.j.cn112137-20200702-02017.
|
| [2] |
|
| [3] |
郑远长. 关于我国失智老年人研究工作综述及相关数据的比较分析[J]. 社会福利(理论版),2021,30(2):3-15.
|
| [4] |
World Health Organization. Global status report on the public health response to dementia[R]. Geneva:World Health Organization,2021.
|
| [5] |
GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050:an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health,2022,7(2):e105-125. DOI:10.1016/s2468-2667(21)00249-8.
|
| [6] | |
| [7] |
Alzheimer's Disease International. Dementia statistics[EB/OL]. [2022-02-01].
|
| [8] |
World Health Organization. Global action plan on the public health response to dementia 2017—2025[R]. Geneva:World Health Organization,2017.
|
| [9] |
Australian Government Department of Health. National framework for action on dementia 2015—2019[EB/OL]. [2022-02-03].
|
| [10] |
Ministry of Health and Welfare. The Third National Dementia Plan in Korea:living well with dementia in the community[EB/OL]. [2022-02-05].
|
| [11] |
Department of Health. Living well with dementia:a National Dementia Strategy[M]. London:Department of Health,2009.
|
| [12] |
Finnish Ministry of Social Affairs and Health. National Memory Programme 2012—2020. Creating a "memory-friendly" Finland[EB/OL]. (2013-03-23)[2022-02-10].
|
| [13] |
Danish Ministry of Health. A safe and dignified life with dementia:national action plan on dementia 2025[EB/OL]. [2022-02-15].
|
| [14] |
Ministry of Health of the Czech Republic. National Action Plan for Alzheimer's disease and other similar diseases 2020—2030[EB/OL]. [2022-03-10].
|
| [15] |
U.S. Department of Health and Human Services. National Plan to Address Alzheimer's disease:2019 update[EB/OL]. [2022-02-20].
|
| [16] |
|
| [17] |
Public Health Agency of Canada. A dementia strategy for Canada:together we aspire(2019)[EB/OL]. [2022-03-11].
|
| [18] |
Ministry of Health Republic of Indonesia. National strategy management of Alzheimer and other dementia diseases:towards healthy and productive older persons[EB/OL]. [2022-03-11].
|
| [19] |
Ministry of Public Health. Qatar national dementia strategy summary 2018—2022[EB/OL]. [2022-03-11].
|
| [20] |
Federal Ministry Labour,Social Affairs. Austria—dementia strategy:living well with dementia[EB/OL]. [2022-03-11].
|
| [21] |
Dementia Oversight of Implementation and Impact Group. Dementia action plan for Wales 2018—2022[EB/OL]. (2018-02-14)[2022-03-11].
|
| [22] |
Greek Republic,Ministry of Foreign Affairs. National action plan for dementia:Alzheimer's disease 2015—2020[EB/OL]. [2022-03-15].
|
| [23] |
State of Israel Ministry of Health. Addressing Alzheimer's and other types of dementia:Israel national strategy[EB/OL]. [2022-03-15].
|
| [24] |
Sottish Government. Scotland's national dementia strategy 2017—2020[EB/OL]. (2017-06-28)[2022-03-15].
|
| [25] |
Federal Office of Public Health,Conference of Swiss State Health Directors. Switzerland national dementia strategy 2014—2019[EB/OL]. [2022-03-15].
|
| [26] |
Luxembourg's Health and Family Ministries. National dementia action plan[EB/OL]. [2022-03-15].
|
| [27] |
Norwegian Ministry of Health and Care Services. Norway-dementia plan 2015—2020[EB/OL].[2022-03-15].
|
| [28] |
The Alzheimer Society of Ireland. Ireland-national dementia strategy 2011—2016[EB/OL].[2022-03-15].
|
| [29] |
Ministry of Health,Welfare and Sport. National dementia strategy 2021—2030[EB/OL].[2022-03-15].
|
| [30] |
Parliamentary Secretariat for Rights of Persons with Disability and Active Ageing. Malta-empowering change 2015—2023[EB/OL].[2022-03-15].
|
| [31] |
Ministry of Health. National dementia strategy 2014[EB/OL].[2022-03-15].
|
| [32] |
Slovenia. National Plan 2016—2020[EB/OL].[2022-03-15].
|
| [33] |
宁吉喆. 第七次全国人口普查主要数据情况[J]. 中国统计,2021,69(5):4-5.
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
国家卫生健康委办公厅关于探索开展抑郁症、老年痴呆防治特色服务工作的通知[A/OL]. [2022-04-05].
|
| [38] |
|
| [39] |
World Health Organization. Risk reduction of cognitive decline and dementia WHO guidelines,2019[EB/OL]. [2022-04-05].
|
| [1] | LI Wenping, CHEN Jianhua, XU Jiapei, JIN Xue, PAN Zihan, CHI Chunhua. A Scoping Review on the Empowerment of Community Elderly Health Services by Digital-Intelligent Health Management Platforms [J]. Chinese General Practice, 2026, 29(21): 2938-2949. |
| [2] | FENG Yuxi, WANG Jinjin, CAI Yi, ZHU Runzhi, ZHU Qin. Research Progress on Protein Lactylation in Kidney Diseases [J]. Chinese General Practice, 2026, 29(21): 3056-3063. |
| [3] | CHENG Yu, HAN Shiyao, SUN Ping, XIANG Juan, YANG Hui, LI Dongze, ZHENG Li, LIAO Xiaoyang. Analysis of Socioeconomic and Demographic Challenges in Chronic Disease Management [J]. Chinese General Practice, 2026, 29(20): 2800-2807. |
| [4] | ZHANG Mingyue, HOU Yan. Research Progress of Exhaled Nitric Oxide and Alveolar Nitric Oxide in Interstitial Lung Diseases [J]. Chinese General Practice, 2026, 29(18): 2571-2576. |
| [5] | CHEN Yiping, ZHANG Jianmei, LI Yanhu, LI Rui, ZHANG Ruiping, YANG Ping. Advances in the Diagnosis and Treatment of Post-COVID-19 Condition of Myocardial Injury [J]. Chinese General Practice, 2026, 29(18): 2585-2592. |
| [6] | MA Xiaoyu, MA Xiaomei, WU Guozhi, ZHENG Ya, GUO Qinghong. Research Progress of Neutrophil Extracellular Traps in Gastric Cancer [J]. Chinese General Practice, 2026, 29(17): 2425-2432. |
| [7] | LI Jiawei, GE Aoqi, GAO Xinyi, LI Juanjuan, YUAN Beibei. The Concept, Connotation, and Pathways of the Integration of Medical Care and Preventive Services in China: a Systematic Review [J]. Chinese General Practice, 2026, 29(16): 2156-2166. |
| [8] | WANG Yang, JIN Hua, YANG Sen, YANG Hui, YU Dehua. Reconfiguring the Functional Features of Primary Care in a Non-gatekeeping Context: a 15-Year Mixed-methods Systematic Review from China [J]. Chinese General Practice, 2026, 29(16): 2140-2155. |
| [9] | CHEN Yan, SHEN Dequan, SHENG Renlei, CHANG Yujie, YANG Jiaqi, DING Jie, SUN Zhifang, WANG Dahui. Influencing Factors and Importance Ranking of the Utilization of Primary-level Traditional Chinese Medicine Preventive and Health Care Services for the Elderly [J]. Chinese General Practice, 2026, 29(16): 2182-2189. |
| [10] | ZOU Jian, LI Wanping, GE Handa, JIN Zhe, RUFEINA· Tuerxun, LI Juan, WEI Anhua, FENG Da. Study on Potentially Inappropriate Medication Use among the Community Elderly Patients in Hubei Province [J]. Chinese General Practice, 2026, 29(13): 1759-1765. |
| [11] | ZHANG Qiang, ZHAO Wenxia, WANG Ziyi, YAN Le, LIANG Haowei, WANG Jinfan, FANG Jinhua, LU Cuncun. Interpretation of the Reporting Guideline for Systematic Reviews of Outcome Measurement Instruments (PRISMA-COSMIN for OMIs 2024) [J]. Chinese General Practice, 2026, 29(13): 1766-1775. |
| [12] | SHI Yufeng, LU Chenxia, LYU Anqi, LI Xiaodong. Research Progress on the Relationship between Veillonella and Liver Diseases Based on the Theory of Intestinal-hepatic Axis [J]. Chinese General Practice, 2026, 29(11): 1488-1496. |
| [13] | YE Xinying, YIN Ankang, LIU Dingling, LYU Xiang, WANG Yi. The Development of General Practice Department in General Hospitals under the DIP Payment Model [J]. Chinese General Practice, 2026, 29(11): 1378-1384. |
| [14] | SUN Yuchen, SHI Yaxin, SHI Wei. Advancements in the Treatment of Endometrial Hypofunction Diseases Using Menstrual Blood-derived Endometrium Stem Cells Combined with Traditional Chinese Medicine for Tonifying Kidney and Activating Blood in Regenerative Medicine [J]. Chinese General Practice, 2026, 29(11): 1481-1487. |
| [15] | YANG Xu, FAN Jieting, SONG Hongyan, FENG Panpan, HAO Jingyu, YAO Mi. Risk Assessment and Communication Strategies for Cardiovascular Diseases in Primary Care [J]. Chinese General Practice, 2026, 29(10): 1294-1299. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||